The active form of vitamin D, 1,25-dihydroxyvitamin D 3 , is known to be produced at sites of granulomatous reactions in sarcoidosis. 1,25-dihydroxyvitamin D 3 has multiple immunomodulatory effects, and acts as a promoter of multinucleated giant cell formation. Polymorphism of the vitamin D receptor (VDR) gene has recently been shown to be related to bone mineral density, and also associated with hyperparathyroidism and risk of prostatic carcinoma. Considering that this might affect sarcoidosis, we investigated polymorphism of the VDR gene in 101 patients with sarcoidosis and 105 healthy control subjects. Their genotypes were determined using polymerase chain reaction (PCR) and restriction fragment length polymorphism. In the patients with sarcoidosis, the BB, Bb, and bb genotypes accounted for 1.0%, 37.6%, and 61.4%, whereas in healthy control subjects the figures were 1.0%, 20.0%, and 79.0%, respectively. The difference in the genotype distribution between healthy control subjects and sarcoidosis patients was significant (p Ͻ 0.05) with the frequency of the B allele being elevated (p Ͻ 0.05). From the result, we suggest that in VDR gene polymorphism the B allele might be a genetic risk factor for sarcoidosis. Niimi T,
Sarcoidosis is a systematic granulomatous disorder of unknown etiology. The active form of vitamin D, 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ] is produced at sites of granulomatous reactions in sarcoidosis (1) (2) (3) . This secosteroid hormone has multiple immunomodulatory effects (1) (2) (3) (4) (5) (6) , and is also reported to be a promoter of multinucleated giant cell formation (3, 7, 8) . 1,25(OH) 2 D 3 is considered to be associated with granuloma formation in sarcoidosis (3, 8) .
The hormone binds to nuclear vitamin D receptors. Polymorphism of the vitamin D receptor (VDR) gene recognized by the Bsm 1 restriction enzyme has recently been shown to be related to bone mineral density. The polymorphism exists on twelfth chromosome intron 8 and can be detected with endonuclease Bsm 1. There are three genotypes, homozygous for the digestive allele "bb," homozygous of undigestive allele "BB," and heterozygous "Bb" (9) (10) . Recent studies revealed that this polymorphism and closely linked variations may have significance for hyperparathyroidism and risk of prostatic carcinoma (11) (12) (13) . Our hypothesis was that it might also affect sarcoidosis, and therefore we investigated polymorphism of the VDR gene recognized by Bsm 1 in a series of patients and control subjects.
METHODS

Study Population
The 101 patients with sarcoidosis studied (82 females, 19 males) were all inhabitants of central Japan. Sarcoidosis was diagnosed on the basis of the clinical picture and the presence of epithelioid cell granulomas in biopsy specimens from lung, skin, or lymph nodes. They had a mean age of 56.1 Ϯ 15.4 yr (mean Ϯ SD). Regarding the roentgenographic stage of patients at the first visit to our hospital, all but 12 had chest X-ray evidence of sarcoidosis, 73 with stage I, ten with stage II, and six with stage III disease.
As healthy controls, 105 unrelated healthy subjects living in the same area of Japan were selected. They were composed of 60 females and 45 males with a mean age of 45.4 Ϯ 14.7 yr. They did not have any past history of pulmonary disease or any abnormalities on physical examination, chest radiography, electrocardiogram (ECG), urinalysis, and routine laboratory blood testing. None was receiving medication at the time of the evaluation. Informed consent was obtained from all the subjects.
Determination of the VDR Genotype
DNA was extracted from peripheral leukocytes with standard techniques. The polymerase chain reaction (PCR) and digestion of PCR products were performed as described by Morrison and coworkers (9) . Specific oligonucleotide primers (5 Ј -CAA CCA AGA CTA CAA GTA CCG CGT CAG TGA-3 Ј , and 5 Ј -AAC CAG CGG GAA GAG GTC AAG GG-3 Ј ) were utilized with PCR to amplify the fragment of the VDR gene including the Bsm 1 restriction site in intron 8. PCR was performed using denaturation at 94 Њ C for 5 min, followed by 35 cycles at 94 Њ C for 45 s, 60 Њ C for 1 min, and 72 Њ C for 1.5 min and a final extension at 72 Њ C for 7 min (DNA Thermal Cycler 2400; Perkin Elmer-Cetus, Norwalk, CT). PCR products were digested with 1.5 U of Bsm 1 (New England Biolabs, Beverly, MA) at 65 Њ C for 2 h, and run on a 2% ethidium bromide-agarose gel. Bsm 1 causes restriction ( November 25, 1998 and in revised form February 9, 1999 ) Supported in part by grants for research into intractable disease from the Ministry of Health and Welfare, Japan, and grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan.
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cleavage of the VDR allele denoted b, whereby the patterns BB, Bb, or bb can be distinguished (Figure 1 ).
Statistical Analysis
The allele ratios and genotype distributions in sarcoidosis patients and healthy control subjects, roentgenographic stages, organ involvement and disappearance of shadows on chest radiography among the three genotypes were analyzed with the chi-square test. The Fisher exact test was also applied for comparison of small populations with expected values less than 5. A p value Ͻ 0.05 was considered significant.
RESULTS
Of the 105 healthy control subjects, 1 had the BB genotype (1.0%), 21 the Bb type (20.0%), and 83 bb type (79.0%). The B allele/b allele (B/b) ratio was 0.110/0.890. Of the 101 sarcoidosis patients, 1 was type BB (1.0%), 38 were Bb (37.6%), and 62 were bb (61.4%). The B/b ratio was 0.198/0.802. A significant difference in the genotype distribution between healthy control subjects and sarcoidosis patients (p Ͻ 0.05), and a significant increase in the frequency of the B allele (p Ͻ 0.05) were observed (Table 1) . We examined genotype distributions among the three roentgenographic stages of sarcoidosis patients, but found no significant correlation with the VDR genotype (Table 2) . Next, we examined the relationship with organ involvement. Cases of eye, skin, heart, and involvement of three or more organs were examined, but the results indicated no specific association with the genotype (data not shown). We also examined the association of genotype distribution and disappearance of shadow on chest radiography within 3 yr, but no line was found (data not shown).
DISCUSSION
In this study, we found a significant difference in the genotype distribution between healthy control subjects and patients with sarcoidosis, the frequency of the B allele in sarcoidosis patients being elevated, although no correlation between genotype and clinical form of the disease was apparent. The genotype distribution established for the healthy subjects in our study was similar to that reported earlier for a larger population of Japanese (14) . These results suggest the VDR gene polymorphism is related to risk of sarcoidosis.
1,25(OH) 2 D 3 has a modulating effect on the human immune response regarding production of several cytokines and immunoglobulin. Its binding to the receptor inhibits antigeninduced lymphocyte proliferation and immunoglobulin production, and inhibits the production of several lymphokines, including interleukin-2, interferon gamma, and granulocytemacrophage colony-stimulating factor (1) (2) (3) (4) (5) . In addition, 1,25-(OH) 2 D 3 acts as a promotor of monocyte/macrophage differentiation (3, 4, 6) , and has biological effects on cells of this lineage including stimulation of the mitotic activity of blood monocytes and promotion of multinucleated giant cell formation (3, 7, 8) . Recent studies showed that VDR gene polymorphism affects messenger RNA stability, and VDR messenger RNA expression is reduced in bb genotype in comparison with BB genotype individuals (9, 15) . Therefore, we suggest that the granulomatous reaction might be suppressed in the bb type as compared with other genotypes because of a decreased potency of 1,25-(OH) 2 D 3 . In the present series of patients with sarcoidosis, significant increase of the frequency of B allele was observed. The mechanistic details remain unclear, but our results suggest that VDR gene polymorphism might play an important role and that the B allele might be a genetic risk factor for sarcoidosis. However, our sarcoidosis cases were predominantly stage I patients, possibly owing to racial variation as well as early detection on medical checkups in Japan. This limitation should be borne in mind in interpretation of the results. Firm conclusions can only be drawn for stage I patients.
Several studies of VDR gene polymorphism have revealed a higher frequency of the B allele in white individuals than Japanese or other Asian individuals (9-11, 14, 16, 17) . Previous epidemiological studies have suggested a trend for sarcoidosis to be rare in Asians (18, 19) . Though interpretation of epidemiological comparisons may be difficult, the findings may be consistent with our hypothesis. To our knowledge, this is the first investigation of VDR gene polymorphism in sarcoidosis. Further investigation of the general association of this source of variation with regard to sarcoidosis and other granulomatous diseases in white individuals and in other Asian groups appears warranted.
